{
    "code": "01048467",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01048467",
    "time": "2021-04-16 04:44:01",
    "許可證字號": "衛署藥製字第048467號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/12\/21",
    "發證日期": "95\/12\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "",
    "中文品名": "&quot;聯邦&quot; 優達平膜衣錠200毫克",
    "英文品名": "Utapine F.C. Tablet 200mg &quot;Union&quot;",
    "適應症": "思覺失調症、雙極性疾患之躁症發作。",
    "劑型": "116膜衣錠",
    "包裝": "3-1000顆塑膠瓶裝 3-1000顆鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "QUETIAPINE (AS FUMARATE)",
    "限制項目": "01國　產 25監視中學名藥 61完成BE試驗",
    "申請商名稱": "1700702200  聯邦化學製藥股份有限公司",
    "申請商地址": "台北市內湖區瑞光路26巷36弄2號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "6105200026  瑞士藥廠股份有限公司新市廠",
            "製造廠廠址": "台南市新市區中山路182號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037610",
            "成分名稱": "QUETIAPINE (AS FUMARATE)",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}